Aspire Biopharma Holdings, Inc. (ASBP) vs Jupiter Neurosciences, Inc. (JUNS)
A side-by-side comparison of Aspire Biopharma Holdings, Inc. and Jupiter Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASBP
Aspire Biopharma Holdings, Inc.
$8.89HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT
JUNS
Jupiter Neurosciences, Inc.
$2.37HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
Total return — ASBP vs JUNS
growth of $100 · dividends reinvested · last 2yASBP -99.9% (-97.5%/yr)JUNS -99.4% (-92.3%/yr)JUNS compounded faster over this window
Log scale — wide-divergence pair
ASBP JUNS
ASBP vs JUNS: by the numbers
- •JUNS is the larger company ($1M vs $1M market cap).
- •Both run net losses; ASBP's is the smaller (-11314.24% vs -14220.12% net margin).
Metrics side by side
Valuation
| Metric | ASBP | JUNS |
|---|---|---|
| P/S ratio | 10.50 | 17.76 |
| P/B ratio | 0.09 | N/A |
Profitability
| Metric | ASBP | JUNS |
|---|---|---|
| Gross margin | -1.87% | 88.34% |
| Operating margin | -312016.95% | -40873.19% |
| Net margin | -11314.24% | -14220.12% |
| ROE | -93.97% | N/A |
| ROIC | -59.81% | -709.40% |
Growth (annualized)
| Metric | ASBP | JUNS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -47.77% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.